Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Mitchell

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Transplantation|July 21, 2022
Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External ValidationJennifer L Alejo, Jonathan Mitchell, Teresa P-Y Chiang, et al.
Nature Medicine|January 10, 2024
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer ProgrammeAlona Sosinsky, John Ambrose, William Cross, et al.
Science Advances|November 16, 2022
Human genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetesAbhishek Nag, Ryan S Dhindsa, Jonathan Mitchell, et al.
Nature|February 4, 2026
Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomesXueqing Zoe Zou, Fengyuan Hu, Haiyi Lou, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature|August 7, 2024
The genomic landscape of 2,023 colorectal cancersAlex J Cornish, Andreas J Gruber, Ben Kinnersley, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activityOriana Y Teran Pumar, Elton L VanNoy, Abigail Haffey, et al.
Nature|April 16, 2025
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesisMalgorzata Gozdecka, Monika Dudek, Sean Wen, et al.
Hepatology International|March 3, 2026
Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statementEric Kalo, Jacinta Holmes, Purnima Bhat, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Transplantation|July 21, 2022
Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External ValidationJennifer L Alejo, Jonathan Mitchell, Teresa P-Y Chiang, et al.
Nature Medicine|January 10, 2024
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer ProgrammeAlona Sosinsky, John Ambrose, William Cross, et al.
Science Advances|November 16, 2022
Human genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetesAbhishek Nag, Ryan S Dhindsa, Jonathan Mitchell, et al.
Nature|February 4, 2026
Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomesXueqing Zoe Zou, Fengyuan Hu, Haiyi Lou, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature|August 7, 2024
The genomic landscape of 2,023 colorectal cancersAlex J Cornish, Andreas J Gruber, Ben Kinnersley, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activityOriana Y Teran Pumar, Elton L VanNoy, Abigail Haffey, et al.
Nature|April 16, 2025
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesisMalgorzata Gozdecka, Monika Dudek, Sean Wen, et al.
Hepatology International|March 3, 2026
Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statementEric Kalo, Jacinta Holmes, Purnima Bhat, et al.
Pageof 9